Update will include new MRI analyses from the Phase 2b RewinD-LB clinical trial, status of global regulatory discussions, and finalized Phase 3 trial design Additional data from MRI analyses will also ...
On April 7, 2026, CervoMed announced that its representatives would present key aspects of the neflamapimod clinical program at the 2026 Lewy Body Dementia Association Annual Meeting in Atlanta, ...
Speaking to BBC Radio Gloucestershire, Satyam said that music stimulates many different areas of the brain because of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results